Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
6 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Clene Inc.’s names, not what it holds today.
Patents granted
6
6 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
10
since 2001, to Dec 31, 2025
Names they are printed under
3
a subsidiary
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name3 counted
Clene Nanomedicine, Inc. a subsidiary
US, as the owner printed on each patent
9 publishedClene Nanomedicine, Inc, a Nevada corporation a subsidiary
US, as the owner printed on each patent
0 publishedClene Nanomedicine, Inc. a subsidiary
named as the applicant on its applications, in US
1 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Apr 20, 2021 | 10,980,832 | Gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor | Pharmaceuticals | Clene Nanomedicine, Inc. |
| Oct 22, 2019 | 10,449,217 | Gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor | Pharmaceuticals | Clene Nanomedicine, Inc. |
| Oct 15, 2019 | 10,441,608 | Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom | Pharmaceuticals | Clene Nanomedicine, Inc. |
| Oct 9, 2018 | 10,092,007 | Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom | Materials, metallurgy | Clene Nanomedicine, Inc. |
| Jul 31, 2018 | 10,035,192 | Continuous, semicontinuous and batch methods for treating liquids and manufacturing certain constituents (e.g.,nanoparticles) in liquids, apparatuses and nanoparticles and nanoparticle/liquid solution(s) and colloids resulting therefrom | Surface technology, coating | Clene Nanomedicine, Inc. |
| Mar 28, 2017 | 9,603,870 | Gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor | Pharmaceuticals | Clene Nanomedicine, Inc, a Nevada corporation |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Dec 23, 2021 | 2021/0392899 | Continuous Methods for Treating Liquids and Manufacturing Certain Constituents (e.g., Nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle/Liquid Solution(s) Resulting Therefrom | Materials, metallurgy | Clene Nanomedicine, Inc. · patent 12,415,218 granted from it |
| Nov 25, 2021 | 2021/0361699 | Novel Gold-Based Nanocrystals for Medical Treatments and Electrochemical Manufacturing Processes Therefor | Pharmaceuticals | Clene Nanomedicine, Inc. |
| Aug 5, 2021 | 2021/0236542 | NOVEL GOLD-BASED NANOCRYSTALS FOR MEDICAL TREATMENTS AND ELECTROCHEMICAL MANUFACTURING PROCESSES THEREFOR | Pharmaceuticals | Clene Nanomedicine, Inc. |
| Feb 25, 2021 | 2021/0052638 | Continuous methods for treating liquids and manufacturing certain constituents (e.g., nanoparticles) in liquds, apparatuses and nanoparticles and nanoparticle/liquid solution(s) resulting therefrom | Pharmaceuticals | Clene Nanomedicine, Inc. |
| Jun 18, 2020 | 2020/0188429 | Novel Gold-Based Nanocrystals for Medical Treatments and Electrochemical Manufacturing Processes Therefor | Pharmaceuticals | Clene Nanomedicine, Inc. · patent 10,980,832 granted from it |
| Feb 28, 2019 | 2019/0059386 | Continuous Methods for Treating Liquids and Manufacturing Certain Constituents (e.g., Nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle/Liquid Solution(s) Resulting Therefrom | Materials, metallurgy | Clene Nanomedicine, Inc. · patent 11,000,042 granted from it |
| Jan 10, 2019 | 2019/0009342 | Continuous, Semicontinuous and Batch Methods for Treating Liquids and Manufacturing Certain Constituents (e.g., Nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle/Liquid Solution(s) and Colloids Resulting Therefrom | Materials, metallurgy | Clene Nanomedicine, Inc. · patent 11,007,573 granted from it |
| Aug 16, 2018 | 2018/0228838 | Methods and Treatment for Certain Demyelination and Dysmyelination-Based Disorders and/or Promoting Remyelination | Pharmaceuticals | Clene Nanomedicine, Inc. |
| Dec 28, 2017 | 2017/0367345 | Continuous Methods for Treating Liquids and Manufacturing Certain Constituents (e.g., Nanoparticles) in Liquids, Apparatuses and Nanoparticles and Nanoparticle/Liquid Solution(s) Resulting Therefrom | Materials, metallurgy | Clene Nanomedicine, Inc. · patent 10,092,007 granted from it |
| Dec 7, 2017 | 2017/0348350 | Novel Gold-Based Nanocrystals for Medical Treatments and Electrochemical Manufacturing Processes Therefor | Pharmaceuticals | Clene Nanomedicine, Inc. · patent 10,449,217 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.